|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 109.00 TWD | -5.22% |
|
-6.84% | -64.14% |
| Market Cap | 7.28B 225M 196M 181M 167M 315M 21.64B 322M 2.17B 852M 10.6B 844M 825M 36.48B | P/E 2024 |
524x | P/E 2025 | -255x |
|---|---|---|---|---|---|
| Enterprise Value | 4.99B 154M 135M 124M 114M 216M 14.82B 220M 1.48B 584M 7.26B 578M 565M 24.99B | EV / Sales 2024 |
1,207x | EV / Sales 2025 | 6,544x |
| Free-Float |
56.63% | Yield 2024 |
0.18% | Yield 2025 | 0.03% |
| 1 day | -5.22% | ||
| 1 week | -6.84% | ||
| Current month | -6.44% | ||
| 1 month | -9.92% | ||
| 3 months | -35.12% | ||
| 6 months | -59.02% | ||
| Current year | -64.14% |
| 1 week | 108 |  | 118 |
| 1 month | 108 | | 135.5 |
| Current year | 108 | | 313 |
| 1 year | 108 | | 317 |
| 3 years | 108 | | 465 |
| 5 years | 42.8 | | 465 |
| 10 years | 42.8 | | 465 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yung Shun Wen
CEO | Chief Executive Officer | - | 2016-09-22 |
Vivian Kang
DFI | Director of Finance/CFO | - | 2019-10-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Lin
CHM | Chairman | - | 2016-09-22 |
Yung Shun Wen
BRD | Director/Board Member | - | 2016-09-22 |
Cheng Yu Fang
BRD | Director/Board Member | - | 2018-08-06 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.22% | -6.84% | -27.81% | -24.57% | 225M | |
| -0.10% | +3.21% | +59.45% | +20.34% | 315B | |
| -1.20% | -2.43% | +23.24% | -8.31% | 67.81B | |
| +0.35% | +2.11% | +37.84% | +86.59% | 9.23B | |
| +0.34% | +0.51% | +5.21% | -0.69% | 8.56B | |
| +1.53% | -3.64% | -22.91% | +5.31% | 4.18B | |
| -11.03% | -12.07% | -8.02% | +14.00% | 3.59B | |
| +1.87% | +3.36% | -46.36% | +28.62% | 3.55B | |
| -0.35% | -0.87% | +48.55% | +60.56% | 2.79B | |
| -7.41% | -2.37% | +3.91% | -23.64% | 2.09B | |
| Average | -2.12% | -1.98% | +7.31% | +15.82% | 41.69B | |
| Weighted average by Cap. | -0.36% | +1.01% | +49.26% | +16.60% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 5.82M 180K 157K 145K 133K 251K 17.29M 257K 1.73M 681K 8.47M 674K 659K 29.14M | 2.75M 84.95K 74.24K 68.51K 63.15K 119K 8.18M 122K 819K 322K 4.01M 319K 312K 13.79M |
| Net income | 18.17M 561K 490K 452K 417K 786K 54M 803K 5.4M 2.13M 26.45M 2.11M 2.06M 91.04M | -79.68M -2.46M -2.15M -1.98M -1.83M -3.44M -237M -3.52M -23.7M -9.32M -116M -9.23M -9.03M -399M |
| Net Debt | -2.43B -75M -65.54M -60.48M -55.75M -105M -7.22B -107M -723M -284M -3.54B -282M -275M -12.18B | -2.29B -70.75M -61.83M -57.06M -52.59M -99.12M -6.81B -101M -682M -268M -3.34B -266M -260M -11.49B |
Employees
32
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | NT$109.00 | -5.22% | 152,346 |
| 26-07-16 | NT$115.00 | -0.86% | 39,310 |
| 26-07-15 | NT$116.00 | +2.20% | 63,636 |
| 26-07-14 | NT$113.50 | -0.44% | 112,167 |
| 26-07-13 | NT$114.00 | -2.56% | 101,162 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 6785 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
